Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Hair repigmentation can indicate malignancy and should be investigated.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Hirsutism is common in young females and may signal underlying hormonal issues.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.

LH and hCG reduce certain protein levels in women's skin.

VEGF165 influences hair follicle cell growth and movement through VEGFR-2 activation.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The nano-carrier makes etoposide safer and more effective against lung cancer.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.